Ad is loading...
DEQCX
Price
$14.87
Change
+$0.09 (+0.61%)
Updated
Nov 21 closing price
DGEFX
Price
$13.01
Change
+$0.11 (+0.85%)
Updated
Nov 21 closing price
Ad is loading...

DEQCX vs DGEFX

Header iconDEQCX vs DGEFX Comparison
Open Charts DEQCX vs DGEFXBanner chart's image
BNY Mellon Global Equity Income - C
Price$14.87
Change+$0.09 (+0.61%)
VolumeN/A
CapitalizationN/A
Destinations Equity Income I
Price$13.01
Change+$0.11 (+0.85%)
VolumeN/A
CapitalizationN/A
DEQCX vs DGEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DEQCX vs. DGEFX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEQCX is a Buy and DGEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DGEFX has more cash in the bank: 527M vs. DEQCX (217M). DGEFX pays higher dividends than DEQCX: DGEFX (2.98) vs DEQCX (1.45). DEQCX was incepted earlier than DGEFX: DEQCX (17 years) vs DGEFX (8 years). DEQCX is a more actively managed with annual turnover of: 60.96 vs. DGEFX (46.00). DGEFX has a lower initial minimum investment than DEQCX: DGEFX (0) vs DEQCX (1000). DGEFX annual gain was more profitable for investors over the last year : 22.67 vs. DEQCX (8.22). DGEFX return over 5 years is better than : 41.23 vs. DEQCX (8.46).
DEQCXDGEFXDEQCX / DGEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years8 years-
Gain YTD8.22716.71149%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets217M527M41%
Annual Yield % from dividends1.452.9849%
Returns for 1 year8.2222.6736%
Returns for 3 years-9.3722.88-41%
Returns for 5 years8.4641.2321%
Returns for 10 years21.91N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATNM1.470.08
+5.76%
Actinium Pharmaceuticals
AIG75.981.32
+1.77%
American International Group
FRBA14.490.04
+0.28%
First Bank
OCUL8.52-0.26
-2.96%
Ocular Therapeutix
FRO19.53-0.73
-3.60%
Frontline Plc